tiprankstipranks
Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT

Bolt Biotherapeutics (BOLT) Financial Statements

192 Followers

Bolt Biotherapeutics Financial Overview

Bolt Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-1.663; its P/E ratio is -0.43; Bolt Biotherapeutics is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.48. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 5.27M$ 2.09M$ 2.53M$ 1.43M$ 1.83M
Gross Profit$ 5.27M$ 2.09M$ 2.53M$ 1.43M$ 1.83M
EBIT$ -10.81M$ -17.90M$ -16.26M$ -18.06M$ -18.41M
EBITDA$ -10.61M$ -17.87M-$ -17.98M$ -18.08M
Net Income Common Stockholders$ -10.81M$ -17.90M$ -16.26M$ -18.06M$ -16.98M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 91.35M$ 102.19M$ 119.72M$ 125.87M$ 126.38M
Total Assets$ 142.89M$ 159.78M$ 175.35M$ 190.70M$ 206.18M
Total Debt$ 19.57M$ 20.22M$ 20.86M$ 21.47M$ 22.05M
Net Debt$ -71.78M$ -81.97M$ -98.87M$ -104.39M$ -104.33M
Total Liabilities$ 38.73M$ 47.04M$ 47.10M$ 48.56M$ 48.49M
Stockholders Equity$ 104.16M$ 112.74M$ 128.26M$ 142.16M$ 157.69M
Cash Flow-
Free Cash Flow$ -16.75M$ -14.27M-$ -15.14M$ -23.40M
Operating Cash Flow$ -16.75M$ -14.27M$ -16.75M$ -15.11M$ -23.40M
Investing Cash Flow$ 10.20M$ 15.81M$ 12.66M$ 13.58M$ 28.99M
Financing Cash Flow-$ 106.00K-$ 147.00K-
Currency in USD

Bolt Biotherapeutics Earnings and Revenue History

Bolt Biotherapeutics Debt to Assets

Bolt Biotherapeutics Cash Flow

Bolt Biotherapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis